December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Toni Choueiri: An inspiration to all trainees
Apr 19, 2024, 08:07

Toni Choueiri: An inspiration to all trainees

Toni Choueiri, shared a post by Ziad Bakouny, Hematology/Oncology fellow at Memorial Sloan Kettering Cancer Center, on X, adding:

“An inspiration to all trainees. I present you the inimitable Ziad Bakouny, a Memorial Sloan Kettering Cancer Center fellow, graduate of Brigham and Women’s Medicine Residents and Dana-Farber Lank Center for Genitourinary Oncology!”

Quoting Ziad Bakouny’s post:

“I am absolutely thrilled to be joining the editorial team at JCO Clinical Cancer Informatics for a 5-year term as an Associate Editor. I cannot think of a better team to work with Sanjay Aneja, Madhu Behera, Russell Rockne, Umit Topaloglu and Aakash Desai.

Consider sending us your clinical informatics papers!”

Ziad Bakouny

Source: Toni Choueiri/X and Ziad Bakouny/X 

Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber and past President of the Medical Staff at DFCI (2016-2018). He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA. Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.


About OncoDaily

OncoDaily  was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.